STAT September 19, 2019
Sharon Begley

The upstart direct-to-consumer DNA-testing company Nebula Genomics announced on Thursday that it will offer anonymous genome sequencing, becoming the first to do so amid public concerns about the privacy of genetic data and law enforcement use of public DNA databases to identify suspects.

Customers will be able to purchase Nebula’s whole-genome sequencing “without sharing their name, address, or credit card information,” said Nebula co-founder and chief scientific officer Dennis Grishin.

The technology exists to do that, he and the company’s other co-founders — Harvard University biologist George Church and Kamal Obbad — explain in a paper in Nature Biotechnology, published on Thursday. To pay for testing, customers would use a cryptocurrency such as bitcoin or a prepaid credit or debit...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Precision Medicine, Provider, Technology
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article